AGP Executive Report
Last update: an hour agoCannabis & Health: A Penn State Q&A breaks down what marijuana rescheduling to Schedule III could mean in real life, while UAMS researchers report how Arkansas pregnant patients purchase medical cannabis (1.62% of pregnancies involved purchases). Mental Health & Cannabis Use: A Journal of Affective Disorders study links cannabis use in young adults at risk for bipolar-spectrum conditions to disruptions in daily responsibilities. Policy & Enforcement: The NDLEA says it dismantled a transnational tramadol network, seizing 1.63M pills in fabricated trailer compartments and arresting suspects tied to cross-border trafficking, including alleged cannabis imports. Public Safety Warning: UK Border Force warns travelers about “free holiday” grooming schemes used to smuggle cannabis, citing a sharp rise in arrests. Industry Culture (Non-CBD but cannabis-adjacent): A piece on “Type II” solventless hash argues the market keeps pushing THC-dominant flower instead of balanced concentrates. Research Tools: NIST expands its mass-spectra chemical fingerprint library to identify unknown substances—useful for labs, regulators, and forensics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.